510(k) K864449
K864449 is an FDA 510(k) premarket notification submitted by Canadian Bioclinical, Ltd. for the device "DIGOXIN/RIA KIT COATED TUBE RADIOIMMUNOASSAY KIT". The FDA issued a decision of Substantially Equivalent on February 2, 1987. The device falls under product code DPO (Radioimmunoassay, Digoxin (125-I), Rabbit Antibody, Coated Tube Sep.), a Class II device regulated under 21 CFR 862.3320. Canadian Bioclinical, Ltd. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 2, 1987
- Date Received
- November 12, 1986
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Digoxin (125-I), Rabbit Antibody, Coated Tube Sep.
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type